Madrigal Pharmaceuticals, Inc. MDGL Total Operating Expenses
Total Operating Expenses at other companies
Other financials
Where this comes from
Reported directly by Madrigal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The official record: Madrigal Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Madrigal Pharmaceuticals, Inc.'s total operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Madrigal Pharmaceuticals, Inc.'s total operating expenses?
- Madrigal Pharmaceuticals, Inc. (MDGL) reported total operating expenses of $404.06M in Q1 2026.
- How has Madrigal Pharmaceuticals, Inc.'s total operating expenses changed year-over-year?
- Madrigal Pharmaceuticals, Inc.'s total operating expenses increased by 86.6% year-over-year, from $216.56M to $404.06M.
- What is the long-term trend for Madrigal Pharmaceuticals, Inc.'s total operating expenses?
- Over 4 years (2021 to 2025), Madrigal Pharmaceuticals, Inc.'s total operating expenses has grown at a 50.9% compound annual growth rate (CAGR), from $242.48M to $1.26B.
- What does total operating expenses mean?
- The total cost of operating the business, excluding non-operating items like interest.
- How do you interpret total operating expenses?
- An increase reflects higher operational investment or cost inflation, while a decrease indicates improved cost management or reduced operational activity.
- How does total operating expenses compare across companies?
- Operating expense ratios are frequently compared across the industry to assess management's ability to control overhead relative to clinical and commercial progress.